Authorizing Medicare coverage of anti-obesity drugs seems unlikely at this point, Juliette Cubanski, PhD, MPP, MPH, deputy director of the Program on Medicare Policy at KFF, told Verywell
Patients interested in weight management should speak with a licensed provider about whether semaglutide, Wegovy, Ozempic, tirzepatide, Zepbound, or Mounjaro may be clinically appropriate
Learn more about weight management
But there can be also more severe side effects, such as damage to the pancreas, eyes, gallbladder and kidneys, as well as dangerously low blood sugar levels, acid reflux and hair loss
Theres a possibility for more serious side effects and adverse reactions with semaglutide too, including: Hypoglycemia (low blood sugar) Increased heart rate Serious allergic reactions Pancreatitis (inflammation of the pancreas) Kidney or gallbladder problems Vision changes Depression or suicidal thoughts If you have side effects from Wegovy, compounded semaglutide, or any weight-loss pill, talk to your provider